I-Mab Biopharma raised $220M Series C venture round, led by Hony Capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
Hony CapitalLEAD | Private Equity | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private Equity | — |
| Private | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$220M
Top Valuation
-
I-Mab Biopharma raised $220M in a Series C round.
The round was announced on 06/29/18.
The round was led by Hony Capital.